Found in 5 to 15% of AML, RUNX1 mutations are more frequent in elderly men, in 20–30% of secondary AML, and in 40% AML with minimal differentiation (M0-AML in the French-American-British classification) [108,110]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.